Nantong Keruisi Biopharmaceutical Technology Co., Ltd. has a complete and professional service platform for cardiac safety evaluation of drugs, a new drug R&D platform targeting ion channels, a kinase screening platform and other platforms, providing advanced and professional comprehensive services for domestic and foreign pharmaceutical R&D enterprises. Our company currently has a laboratory area of 2,000 m2, and the R&D platforms will cover levels ranging from cells all the way to gross animal level.
The company is located in Haimen Linjiang New District, which is one of the first batch of biopharmaceutical technology entrepreneurship parks in Jiangsu Province and was awarded a Jiangsu Province New-Type Industrialization Industry Demonstration Base in 2010. At present, there are more than 100 enterprises of various types in the district. Haimen Linjiang New District is a good place containing unlimited business opportunities and suitable for investment and entrepreneurship. Linjiang New District is continuously optimizing the investment and development environment and making every effort to build a green park, a science and technology park, and a humanistic park.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows